New search | Conferencedetail
mail
Print view
 
 

Rare and Genetic Kidney Disease Drug Development Summit

Evvnt Promotion / evvnt
-
30.11.2021 - 02.12.2021  Online
Time: 10:00 am - 5:30 pm
 
Conference themes
Marrying unmissable insights from global renal experts, the 1st Rare and Genetic Kidney Disease Drug Development Summit is uniquely positioned to provide you with transformative perspectives from identifying genetic drivers of rare kidney diseases to innovative trial design in small disease populations to accelerate progress of your genetic kidney disease pipeline.
Professional congress organizer (PCO)
Hanson Wade
Notes
Brochure: https://go.evvnt.com/853526-3?pid=4832

Speakers: Alan Glicklich, Chief Medical Officer, Chinook Therapeutics, Alex Bell, Director Kidney Disease Drug Discovery, Ionis Pharmaceuticals and more
 

Enquiries and Registration:

https://go.evvnt.com/853526-1?pid=4832
Ms. Emily Birt
 
Categories
General Medicine
Languages
English
Congress fees
USD 1899.00 - USD 3397.00
Participants expected
1000
Organizer contact info
83 Great Titchfield Street
W1W 6RH London
United Kingdom
 
"Going International promotes access to education and training for all regardless of social, geographic and national borders."

AGEM - Arbeitsgemeinschaft Ethnologie und MedizinOÖ Gebietskrankenkasse, Referat für Wissenschaftskooperation AMREF - African Medical and Research FoundationAlumni Club Medizinische Universität WienCentro per la Formazione Permanente e l'Aggiornamento del Personale del Servizio SanitarioAnästhesie in Entwicklungsländern e. V.European Health Forum GasteinCenter of Excellence